Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL
3 clinical trials · Condition
◉ Watch Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL
| Record | Firm | Date |
|---|---|---|
| A Study of APG-3288 in Relapsed/Refractory Blood Cancers (NCT07424833) | Ascentage Pharma Group Inc. | 2026-08-01 |
| A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL (NCT07609823) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2026-07-14 |
| A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT04808570) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-06-05 |
Track Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL automatically
Every clearance here is in the API, with alerts when new ones post.